Instil Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Instil Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2024.
  • Instil Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $4.07M, a 12.9% decline year-over-year.
  • Instil Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $17.3M, a 14.5% decline year-over-year.
  • Instil Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $18.2M, a 40.3% decline from 2022.
  • Instil Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $30.4M, a 16.2% increase from 2021.
  • Instil Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $26.2M, a 1436% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $17.3M $4.07M -$602K -12.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $17.9M $4.17M -$240K -5.44% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $18.2M $4.52M -$15K -0.33% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $18.2M $4.55M -$2.09M -31.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $20.3M $4.67M -$3.31M -41.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $23.6M $4.41M -$3.91M -47% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $27.5M $4.53M -$2.96M -39.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $30.4M $6.64M -$2.26M -25.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $32.7M $7.98M -$752K -8.61% Jul 1, 2022 Sep 30, 2022 10-Q/A 2023-11-13
Q2 2022 $33.5M $8.32M +$2.58M +44.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $30.9M $7.49M +$4.68M +166% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $26.2M $8.91M +$8.49M +2051% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $17.7M $8.73M +$8.4M +2539% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $9.3M $5.75M +$4.85M +539% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $4.46M $2.81M +$2.75M +4435% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $1.71M $414K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 $331K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $899K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $62K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.